The Foundation is funding the CRI-AMS project, which aims to identify specific biomarkers of Multiple-system atrophy (MSA), a rare, progressive, untreated and poorly diagnosed disease, with many clinical similarities with other neurodegenerative pathologies. These biomarkers are a key factor in the early prognosis of MSA with is essential in the search for therapeutic research.
To find out more about this project, click on this link: CRI-AMS Project 2025-2026
